Effects of spironolactone and fosinopril on the spontaneous and chronic ventricular arrhythmias in a rat model of myocardial infarction

被引:8
作者
Beck, L
Blanc-Guillemaud, V
Cherif, OK
Jover, B
Davy, JM
机构
[1] INSERM, U 390, Montpellier, France
[2] Univ Montpellier I, Montpellier, France
关键词
ventricular arrhythmias; experimental heart failure; holter monitoring; ACE inhibitors; spironolactone;
D O I
10.1159/000049089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We documented chronic ventricular arrhythmias in a first group of 58 rats after myocardial infarction (MI), then assessed the effects of spironolactone and fosinopril on morphological indexes and arrhythmias in a second group (n = 33). Rats underwent Holter monitoring at 2 months after MI. Treatment was randomly given from 1 until 4 months after MI: placebo in 12 rats (P), fosinopril in 9 (F) and spironolactone + fosinopril in 12 (SF). The score of ventricular premature beats (VPBs) was related to the MI size and the delay from MI (p < 0.01). VPB's reduction/increase required to demonstrate anti/pro-arrhythmic effects were 55 and 59%. Mass indexes were lower in F and SF (p = 0.01). VPB's difference (4 months vs. 1) was positive in P, significantly lower in F and negative in SF (p = 0.04). In this relevant model of spontaneous and chronic ventricular arrhythmias, SF association did not increase mortality but lowered the arrhythmic score. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:85 / 93
页数:9
相关论文
共 26 条
[1]  
Aimond F, 2000, J PHARMACOL EXP THER, V292, P415
[2]   EFFECTS OF ADDING SPIRONOLACTONE TO AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN CHRONIC CONGESTIVE-HEART-FAILURE SECONDARY TO CORONARY-ARTERY DISEASE [J].
BARR, CS ;
LANG, CC ;
HANSON, J ;
ARNOTT, M ;
KENNEDY, N ;
STRUTHERS, AD .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (17) :1259-1265
[3]  
BELICHARD P, 1994, J AM COLL CARDIOL, V23, P505
[4]   SPONTANEOUS ARRHYTHMIAS IN VARIOUS MODELS OF CARDIAC-HYPERTROPHY AND SENESCENCE OF RATS - A HOLTER MONITORING STUDY [J].
CARRE, F ;
LESSARD, Y ;
COUMEL, P ;
OLLIVIER, L ;
BESSE, S ;
LECARPENTIER, Y ;
SWYNGHEDAUW, B .
CARDIOVASCULAR RESEARCH, 1992, 26 (07) :698-705
[5]   TRANDOLAPRIL DECREASES PREVALENCE OF VENTRICULAR ECTOPIC ACTIVITY IN MIDDLE-AGED SHR [J].
CHEVALIER, B ;
HEUDES, D ;
HEYMES, C ;
BASSET, A ;
DAKHLI, T ;
BANSARD, Y ;
JOUQUEY, S ;
HAMON, G ;
BRUNEVAL, P ;
SWYNGHEDAUW, B ;
CARRE, F .
CIRCULATION, 1995, 92 (07) :1947-1953
[6]  
FLETCHER RD, 1993, CIRCULATION, V87, P49
[7]   CARDIAC-FAILURE AND SUDDEN-DEATH IN THE FRAMINGHAM-STUDY [J].
KANNEL, WB ;
PLEHN, JF ;
CUPPLES, LA .
AMERICAN HEART JOURNAL, 1988, 115 (04) :869-875
[8]   Effects of spironolactone on exercise capacity and neurohormonal factors in patients with heart failure treated with loop diuretics and angiotensin-converting enzyme inhibitor [J].
Kinugawa, T ;
Ogino, K ;
Kato, M ;
Furuse, Y ;
Shimoyama, M ;
Mori, M ;
Endo, A ;
Kato, T ;
Omodani, H ;
Osaki, S ;
Miyakoda, H ;
Hisatome, I ;
Shigemasa, C .
GENERAL PHARMACOLOGY, 1998, 31 (01) :93-99
[9]   A CLINICAL-TRIAL OF THE ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR TRANDOLAPRIL IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL-INFARCTION [J].
KOBER, L ;
TORPPEDERSEN, C ;
CARLSEN, JE ;
BAGGER, H ;
ELIASEN, P ;
LYNGBORG, K ;
VIDEBEK, J ;
COLE, DS ;
AUCLERT, L ;
PAULY, NC ;
ALIOT, E ;
PERSSON, S ;
CAMM, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) :1670-1676
[10]   Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients [J].
MacFadyen, RJ ;
Barr, CS ;
Struthers, AD .
CARDIOVASCULAR RESEARCH, 1997, 35 (01) :30-34